Literature DB >> 25890729

Tuning cellular response by modular design of bioactive domains in collagen.

Richard A Que1, Sam Wei Polly Chan2, Abeer M Jabaiah2, Richard H Lathrop3, Nancy A Da Silva4, Szu-Wen Wang5.   

Abstract

Collagen's ability to direct cellular behavior suggests that redesigning it at the molecular level could enable manipulation of cells residing in an engineered microenvironment. However, the fabrication of full-length collagen mimics of specified sequence de novo has been elusive, and applications still rely on material from native tissues. Using a bottom-up strategy, we synthesized modular genes and expressed recombinant human collagen variants in Saccharomyces cerevisiae. The resulting biopolymers contained prescribed cell-interaction sites that can direct and tune cellular responses, with retention of the important triple-helical self-assembled structure. Removal of the native integrin-binding sites GROGER, GAOGER, GLOGEN, GLKGEN, and GMOGER in human collagen III yielded collagen that did not support adhesion of mammalian cells. Introduction of GFOGER sequences to this scaffold at specified locations and densities resulted in varying degrees of cellular attachment. The recruitment of focal adhesion complexes on the different collagens ranged from a 96% reduction to a 56% increase over native collagen I. Adhesion to the GFOGER-containing variants was entirely dependent and partially dependent on the β1 and α2 subunits of integrin, respectively, with cell adhesion on average reduced by 86% with anti-β1 and 38% with anti-α2 integrin antibody incubation. Results support the importance of local context in collagen-cell interactions. The investigation demonstrates the flexibility of this approach to introduce targeted changes throughout the collagen polymer for producing fully-prescribed variants with tailored properties.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Biomimetic material; Cell adhesion; Collagen; Extracellular matrix (ECM); GFOGER; Integrin

Mesh:

Substances:

Year:  2015        PMID: 25890729     DOI: 10.1016/j.biomaterials.2015.02.074

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  6 in total

Review 1.  Extracellular Matrix-Based Strategies for Immunomodulatory Biomaterials Engineering.

Authors:  Andrew T Rowley; Raji R Nagalla; Szu-Wen Wang; Wendy F Liu
Journal:  Adv Healthc Mater       Date:  2019-02-04       Impact factor: 9.933

2.  Effect of N-(2-aminoethyl) ethanolamine on hypertrophic scarring changes in vitro: Finding novel anti-fibrotic therapies.

Authors:  Zhenping Chen; Jianhua Gu; Amina El Ayadi; Andres F Oberhauser; Jia Zhou; Linda E Sousse; Celeste C Finnerty; David N Herndon; Paul J Boor
Journal:  Toxicol Appl Pharmacol       Date:  2018-09-22       Impact factor: 4.219

3.  Recombinant collagen scaffolds as substrates for human neural stem/progenitor cells.

Authors:  Richard A Que; Janahan Arulmoli; Nancy A Da Silva; Lisa A Flanagan; Szu-Wen Wang
Journal:  J Biomed Mater Res A       Date:  2018-01-31       Impact factor: 4.396

4.  Incorporation of a Ligand Peptide for Immune Inhibitory Receptor LAIR-1 on Biomaterial Surfaces Inhibits Macrophage Inflammatory Responses.

Authors:  Yoon Kyung Kim; Shu-Hui Chu; Jessica Y Hsieh; Cody M Kamoku; Andrea J Tenner; Wendy F Liu; Szu-Wen Wang
Journal:  Adv Healthc Mater       Date:  2017-10-30       Impact factor: 9.933

5.  Integrin-specific hydrogels modulate transplanted human bone marrow-derived mesenchymal stem cell survival, engraftment, and reparative activities.

Authors:  Amy Y Clark; Karen E Martin; José R García; Christopher T Johnson; Hannah S Theriault; Woojin M Han; Dennis W Zhou; Edward A Botchwey; Andrés J García
Journal:  Nat Commun       Date:  2020-01-08       Impact factor: 14.919

6.  Mapping the Effect of Gly Mutations in Collagen on α2β1 Integrin Binding.

Authors:  Sezin Yigit; Hongtao Yu; Bo An; Samir Hamaia; Richard W Farndale; David L Kaplan; Yu-Shan Lin; Barbara Brodsky
Journal:  J Biol Chem       Date:  2016-07-18       Impact factor: 5.157

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.